News
Thailand’s Cannabis Gold Rush Comes Under Heavy Scrutiny

Many cannabis dispensaries can be found on Bangkok’s Khao San Road, but it has also been the target of recent crackdowns on unlicensed vendors.
In December, police and officials raided Khao San Road twice, detaining vendors who allowed indoor smoking and arresting stall owners who they claimed were operating without a license.
Hundreds of cannabis dispensaries have sprouted up across Bangkok since cannabis was decriminalized, but a highly conservative society closely scrutinizes the sale of weed for recreational use.
In June 2022, Thailand became the first Southeast Asian country to remove cannabis plant parts from its narcotics list. Removing the plant from the narcotics list effectively legalizes the substance — albeit with a confusing lack of detail.
A bill to regulate cannabis use and sale is still being debated in Parliament.
Cannabis a gold rush in Thailand
The University of Thai Chamber of Commerce predicts the market will be worth US$1.2 billion by 2025, which could be a lucrative change for a tourism-heavy economy badly harmed by the pandemic.
However, without clear regulations, Thailand is quickly becoming a free-wheeling weed Wild West, raising concerns among business owners that the weed gold rush may go bust.
Thailand’s hasty legalization of cannabis drew both praise and criticism, with many concerned about the legal ambiguity.
A heated debate erupted earlier this month in Pattaya after a photo of a tween Thai boy smoking marijuana went viral.
While the government tightened some retail rules earlier this month, prohibiting sales to people under the age of 20 and pregnant women, debate over additional restrictions is still raging in Parliament.
While cannabis has some medicinal benefits, public education is required to ensure that people are aware of the drug’s potential harm, according to Thongchai Lertwilairattanapong of the Department of Thai Traditional Medicine.
“We aim to regulate cannabis like liquor or cigarettes,” he said.
“People must be aware of the dangers of excessive alcohol and cigarette consumption, as well as cannabis, which is a new player in Thailand.”
Experts warn that excessive use can result in a drug-induced psychosis, while long-term use has been linked to asthma, cancers, memory loss, and learning difficulties.
Gloria Lai, regional director of the International Drug Policy Consortium, told the Bangkok Post that decriminalization occurred without proper planning. She said that given their push for this to be available, the government is responsible for educating the public, “Right now, it’s a vacuum.”
Cannabis vendors are to be strictly monitored.
The Public Health Ministry will allow cannabis buds to be sold by more than 5,000 licensed vendors across the country starting next month, with vendor and buyer information being sent to the International Narcotics Control Board (INCB) as part of sales controls.
Thongchai Lertwilairattanapong, director-general of the Department of Thai Traditional and Alternative Medicine (DTAM), stated yesterday that anyone wishing to sell cannabis buds, classified as a controlled substance, must first obtain permission from the department.
Dr. Thongchai stated that the department is establishing a system to track the sale of dried cannabis buds from licensed vendors.
Vendors will be required to provide information about the number of cannabis buds they have in their possession, where they buy, and who they sell to, he said, adding that buyers must be over the age of 20.
Customers must insert their ID card into a device linked to the DTAM system when purchasing cannabis buds.
According to Dr. Thongchai, the necessary information can be checked in real-time and then forwarded to the INCB.
“Thailand currently does not have such information to report to the INCB. We can reassure the INCB about sales controls once the system is in place, “He stated.
Bill to regulate cannabis use
The system is expected to be operational next month, he said, adding that there are approximately 5,000 vendors licensed to sell cannabis and cannabis products across the country.
He estimates that about 2,000 are in Bangkok, mostly in tourist areas like Khao San Road and the Thong Lor neighborhood.
Dr. Thongchai stated that the cannabis and hemp control bill is still being debated in parliament. “Even though the Public Health Ministry has enforced ministerial regulations to control cannabis use, we must admit that this is still insufficient,” he said.
He emphasized the importance of passing the bill to regulate cannabis use, particularly public smoking.
The House committee vetting the bill agreed on Wednesday to remove Section 3, which states that cannabis and hemp are not narcotics under the Narcotics Act.
This has raised concerns about the plant’s legal status, but the Bhumjaithai Party, which sponsored the bill, and the DTAM have insisted that repealing Section 3 will not result in cannabis’s delisting as a narcotic drug being reinstated.
Supachai Jaisamut, chairman of the panel and a list MP for the Bhumjaithai Party, emphasized that the bill was intended to limit recreational cannabis use due to the societal implications.
WEED.in.th, an online map firm, has registered 1,750 stores, with another 450 awaiting approval.
Bill Committee Removes the Section About Cannabis Not Being a Narcotic
Bill Committee Removes the Section About Cannabis Not Being a Narcotic

News
Google’s Search Dominance Is Unwinding, But Still Accounting 48% Search Revenue

Google is so closely associated with its key product that its name is a verb that signifies “search.” However, Google’s dominance in that sector is dwindling.
According to eMarketer, Google will lose control of the US search industry for the first time in decades next year.
Google will remain the dominant search player, accounting for 48% of American search advertising revenue. And, remarkably, Google is still increasing its sales in the field, despite being the dominating player in search since the early days of the George W. Bush administration. However, Amazon is growing at a quicker rate.
Google’s Search Dominance Is Unwinding
Amazon will hold over a quarter of US search ad dollars next year, rising to 27% by 2026, while Google will fall even more, according to eMarketer.
The Wall Street Journal was first to report on the forecast.
Lest you think you’ll have to switch to Bing or Yahoo, this isn’t the end of Google or anything really near.
Google is the fourth-most valued public firm in the world. Its market worth is $2.1 trillion, trailing just Apple, Microsoft, and the AI chip darling Nvidia. It also maintains its dominance in other industries, such as display advertisements, where it dominates alongside Facebook’s parent firm Meta, and video ads on YouTube.
To put those “other” firms in context, each is worth more than Delta Air Lines’ total market value. So, yeah, Google is not going anywhere.
Nonetheless, Google faces numerous dangers to its operations, particularly from antitrust regulators.
On Monday, a federal judge in San Francisco ruled that Google must open up its Google Play Store to competitors, dealing a significant blow to the firm in its long-running battle with Fortnite creator Epic Games. Google announced that it would appeal the verdict.
In August, a federal judge ruled that Google has an illegal monopoly on search. That verdict could lead to the dissolution of the company’s search operation. Another antitrust lawsuit filed last month accuses Google of abusing its dominance in the online advertising business.
Meanwhile, European regulators have compelled Google to follow tough new standards, which have resulted in multiple $1 billion-plus fines.

Pixa Bay
Google’s Search Dominance Is Unwinding
On top of that, the marketplace is becoming more difficult on its own.
TikTok, the fastest-growing social network, is expanding into the search market. And Amazon has accomplished something few other digital titans have done to date: it has established a habit.
When you want to buy anything, you usually go to Amazon, not Google. Amazon then buys adverts to push companies’ products to the top of your search results, increasing sales and earning Amazon a greater portion of the revenue. According to eMarketer, it is expected to generate $27.8 billion in search revenue in the United States next year, trailing only Google’s $62.9 billion total.
And then there’s AI, the technology that (supposedly) will change everything.
Why search in stilted language for “kendall jenner why bad bunny breakup” or “police moving violation driver rights no stop sign” when you can just ask OpenAI’s ChatGPT, “What’s going on with Kendall Jenner and Bad Bunny?” in “I need help fighting a moving violation involving a stop sign that wasn’t visible.” Google is working on exactly this technology with its Gemini product, but its success is far from guaranteed, especially with Apple collaborating with OpenAI and other businesses rapidly joining the market.
A Google spokeswoman referred to a blog post from last week in which the company unveiled ads in its AI overviews (the AI-generated text that appears at the top of search results). It’s Google’s way of expressing its ability to profit on a changing marketplace while retaining its business, even as its consumers steadily transition to ask-and-answer AI and away from search.
Google has long used a single catchphrase to defend itself against opponents who claim it is a monopoly abusing its power: competition is only a click away. Until recently, that seemed comically obtuse. Really? We are going to switch to Bing? Or Duck Duck Go? Give me a break.
But today, it feels more like reality.
Google is in no danger of disappearing. However, every highly dominating company faces some type of reckoning over time. GE, a Dow mainstay for more than a century, was broken up last year and is now a shell of its previous dominance. Sears declared bankruptcy in 2022 and is virtually out of business. US Steel, long the foundation of American manufacturing, is attempting to sell itself to a Japanese corporation.
SOURCE | CNN
News
The Supreme Court Turns Down Biden’s Government Appeal in a Texas Emergency Abortion Matter.

(VOR News) – A ruling that prohibits emergency abortions that contravene the Supreme Court law in the state of Texas, which has one of the most stringent abortion restrictions in the country, has been upheld by the Supreme Court of the United States. The United States Supreme Court upheld this decision.
The justices did not provide any specifics regarding the underlying reasons for their decision to uphold an order from a lower court that declared hospitals cannot be legally obligated to administer abortions if doing so would violate the law in the state of Texas.
Institutions are not required to perform abortions, as stipulated in the decree. The common populace did not investigate any opposing viewpoints. The decision was made just weeks before a presidential election that brought abortion to the forefront of the political agenda.
This decision follows the 2022 Supreme Court ruling that ended abortion nationwide.
In response to a request from the administration of Vice President Joe Biden to overturn the lower court’s decision, the justices expressed their disapproval.
The government contends that hospitals are obligated to perform abortions in compliance with federal legislation when the health or life of an expectant patient is in an exceedingly precarious condition.
This is the case in regions where the procedure is prohibited. The difficulty hospitals in Texas and other states are experiencing in determining whether or not routine care could be in violation of stringent state laws that prohibit abortion has resulted in an increase in the number of complaints concerning pregnant women who are experiencing medical distress being turned away from emergency rooms.
The administration cited the Supreme Court’s ruling in a case that bore a striking resemblance to the one that was presented to it in Idaho at the beginning of the year. The justices took a limited decision in that case to allow the continuation of emergency abortions without interruption while a lawsuit was still being heard.
In contrast, Texas has been a vocal proponent of the injunction’s continued enforcement. Texas has argued that its circumstances are distinct from those of Idaho, as the state does have an exemption for situations that pose a significant hazard to the health of an expectant patient.
According to the state, the discrepancy is the result of this exemption. The state of Idaho had a provision that safeguarded a woman’s life when the issue was first broached; however, it did not include protection for her health.
Certified medical practitioners are not obligated to wait until a woman’s life is in imminent peril before they are legally permitted to perform an abortion, as determined by the state supreme court.
The state of Texas highlighted this to the Supreme Court.
Nevertheless, medical professionals have criticized the Texas statute as being perilously ambiguous, and a medical board has declined to provide a list of all the disorders that are eligible for an exception. Furthermore, the statute has been criticized for its hazardous ambiguity.
For an extended period, termination of pregnancies has been a standard procedure in medical treatment for individuals who have been experiencing significant issues. It is implemented in this manner to prevent catastrophic outcomes, such as sepsis, organ failure, and other severe scenarios.
Nevertheless, medical professionals and hospitals in Texas and other states with strict abortion laws have noted that it is uncertain whether or not these terminations could be in violation of abortion prohibitions that include the possibility of a prison sentence. This is the case in regions where abortion prohibitions are exceedingly restrictive.
Following the Supreme Court’s decision to overturn Roe v. Wade, which resulted in restrictions on the rights of women to have abortions in several Republican-ruled states, the Texas case was revisited in 2022.
As per the orders that were disclosed by the administration of Vice President Joe Biden, hospitals are still required to provide abortions in cases that are classified as dire emergency.
As stipulated in a piece of health care legislation, the majority of hospitals are obligated to provide medical assistance to patients who are experiencing medical distress. This is in accordance with the law.
The state of Texas maintained that hospitals should not be obligated to provide abortions throughout the litigation, as doing so would violate the state’s constitutional prohibition on abortions. In its January judgment, the 5th United States Circuit Court of Appeals concurred with the state and acknowledged that the administration had exceeded its authority.
SOURCE: AP
SEE ALSO:
Could Last-Minute Surprises Derail Kamala Harris’ Campaign? “Nostradamus” Explains the US Poll.
News
Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli, To repay $6.4 Million

Washington — The Supreme Court rejected Martin Shkreli’s appeal on Monday, after he was branded “Pharma Bro” for raising the price of a lifesaving prescription.
Martin appealed a decision to repay $64.6 million in profits he and his former company earned after monopolizing the pharmaceutical market and dramatically raising its price. His lawyers claimed the money went to his company rather than him personally.
The justices did not explain their reasoning, as is customary, and there were no notable dissents.
Prosecutors, conversely, claimed that the firm had promised to pay $40 million in a settlement and that because Martin orchestrated the plan, he should be held accountable for returning profits.
Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli
Martin was also forced to forfeit the Wu-Tang Clan’s unreleased album “Once Upon a Time in Shaolin,” which has been dubbed the world’s rarest musical album. The multiplatinum hip-hop group auctioned off a single copy of the record in 2015, stipulating that it not be used commercially.
Shkreli was convicted of lying to investors and defrauding them of millions of dollars in two unsuccessful hedge funds he managed. Shkreli was the CEO of Turing Pharmaceuticals (later Vyera), which hiked the price of Daraprim from $13.50 to $750 per pill after acquiring exclusive rights to the decades-old medicine in 2015. It cures a rare parasite condition that affects pregnant women, cancer patients, and HIV patients.
He defended the choice as an example of capitalism in action, claiming that insurance and other programs ensured that those in need of Daraprim would eventually receive it. However, the move prompted criticism, from the medical community to Congress.
Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli
Attorney Thomas Huff said the Supreme Court’s Monday ruling was upsetting, but the high court could still overturn a lower court judgment that allowed the $64 million penalty order even though Shkreli had not personally received the money.
“If and when the Supreme Court does so, Mr. Shkreli will have a strong argument for modifying the order accordingly,” he told reporters.
Shkreli was freed from prison in 2022 after serving most of his seven-year sentence.
SOURCE | AP
-
News4 years ago
Let’s Know About Ultra High Net Worth Individual
-
Entertainment2 years ago
Mabelle Prior: The Voice of Hope, Resilience, and Diversity Inspiring Generations
-
Health4 years ago
How Much Ivermectin Should You Take?
-
Tech2 years ago
Top Forex Brokers of 2023: Reviews and Analysis for Successful Trading
-
Lifestyles3 years ago
Aries Soulmate Signs
-
Movies2 years ago
What Should I Do If Disney Plus Keeps Logging Me Out of TV?
-
Health3 years ago
Can I Buy Ivermectin Without A Prescription in the USA?
-
Learning3 years ago
Virtual Numbers: What Are They For?